01 Jan Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults -60 years of age
Posted at 00:00h
in
Authored by: Vermeulen Joost N., Lange Joep M. A., Tyring Stephen K., Peters Patrick H., Nunez Margaret, Poland Gregory, Levin Myron J., Freeman Carrie, Chalikonda Ira, Li Jianjun, Smith Jeffrey G., Caulfield Michael J., Stek Jon E., Chan Ivan S. F., Vessey Rupert, Schödel Florian P., Annunziato Paula W., Schlienger Katia, Silber Jeffrey L.
In: VACCINE 30(5), 2012, p.904-910
http://www.ncbi.nlm.nih.gov/pubmed/22154769